<!DOCTYPE html>
<html>

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, shrink-to-fit=no">
    <title>Current News - Sannidhi Sarvadhavabhatla</title>
    <link rel="stylesheet" href="/assets/bootstrap/css/bootstrap.min.css?h=3dabf807fbe5892b04375197d1713429">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,400i,700,700i,600,600i">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/ionicons/2.0.1/css/ionicons.min.css">
    <link rel="stylesheet" href="/assets/css/styles.min.css?h=572324683fcfd646afd8767479ac374a">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/baguettebox.js/1.10.0/baguetteBox.min.css">
</head>

<body>
    <nav class="navbar navbar-light navbar-expand-lg clean-navbar" style="width: Auto;height: Auto;padding: 0;padding-right: 0;padding-top: 20px;padding-bottom: 20px;background-color: rgb(41,40,41);">
        <div class="container"><a class="navbar-brand text-sm-center logo" href="/index.html" style="margin: 0px;font-size: 20px;color: rgba(238,234,234,0.9);">Sannidhi Sarvadhavabhatla</a><button data-toggle="collapse" class="navbar-toggler" data-target="#navcol-1" style="width: 56px;background-color: rgba(255,253,253,0);color: rgba(255,255,255,0.5);"><span class="sr-only">Toggle navigation</span><span class="navbar-toggler-icon" style="background-color: #ffffff;color: rgba(255,255,255,0.5);width: 26px;"></span></button>
            <div class="collapse navbar-collapse text-left" id="navcol-1">
                <ul class="navbar-nav ml-auto">
                    <li class="nav-item"><a class="nav-link" href="/index.html" style="color: rgba(238,234,234,0.9);">Home</a></li>
                    <li class="nav-item"><a class="nav-link active" href="/current-news.html" style="color: rgba(238,234,234,0.9);">current news</a></li>
                    <li class="nav-item"><a class="nav-link" href="/blog.html" style="color: rgba(238,234,234,0.9);">Blog</a></li>
                    <li class="nav-item"><a class="nav-link" href="/about-me.html" style="color: rgba(238,234,234,0.9);">About ME</a></li>
                    <li class="nav-item"><a class="nav-link" href="/contact-me.html" style="color: rgba(238,234,234,0.9);">ContacT</a></li>
                </ul>
            </div>
        </div>
    </nav>
    <main class="page blog-post-list">
        <section class="clean-block clean-blog-list dark">
            <div class="container">
                <div class="block-heading">
                    <h2 style="color: rgb(127, 117, 132);">Current News/Publications</h2>
                </div>
                <div class="block-content">
                    <div class="clean-blog-post">
                        <div class="row">
                            <div class="col-lg-5"><img class="rounded img-fluid" src="/assets/img/download.png?h=d8dc8a826ce4b2a33b6280c5dc629eaf"></div>
                            <div class="col-lg-7 text-left">
                                <h3 class="text-left">How the Moderna vaccine differs from Pfizer's</h3>
                                <div class="info"></div>
                                <p class="text-left">According to the FDA, the Moderna vaccine was 94.1% effective at preventing symptomatic cases. The Pfizer vaccine has claimed 95% effectiveness. Both vaccines require two doses, however. Both shots, can cause some temporary discomfort, just like many vaccines do. In addition to a sore arm, people can experience a fever and some flu-like symptoms — fatigue, aches, chills, or headache. While both vaccines uses mRNA molecules, the main difference between the two vaccines is that they have different lipid delivery systems, meaning the sort of fatty droplet in which the messenger RNA is located. Moderna has filed a EUA with the FDA and is awaiting a response. Moderna's mRNA-1273 phase 1 trial findings can be found at the link below.&nbsp;<br>&nbsp;<a class="underline" href="https://www.nejm.org/doi/10.1056/NEJMoa2022483" style="color: rgb(0,0,0);border-style: none;border-color: rgb(0,0,0);">Read More...</a></p>
                            </div>
                        </div>
                    </div>
                    <div class="text-left clean-blog-post">
                        <div class="row">
                            <div class="col-lg-5"><img class="rounded img-fluid" src="/assets/img/Pfizer.svg.png?h=a8932de25fdf042a446523ed98088aea"></div>
                            <div class="col-lg-7 text-left">
                                <h3 class="text-left">Pfizer vaccine is out: Summary of their phase 2/3 trial results of the BNT162b2 mRNA covid-19 vaccine</h3>
                                <p class="text-left">Pfizer published their phase 2/3 trial results in the NEJM on December 10, 2020. A total of 43,548 participants underwent randomization, of whom 43,448 received injections: 21,720 with BNT162b2 and 21,728 with placebo. The main findings from their study was that "8 cases of Covid-19 with onset at least 7 days after the second dose among participants assigned to receive BNT162b2 and 162 cases among those assigned to placebo" (Pfizer). Their main conclusion was that the BNT162b2 mRNA vaccine was 95% effective in preventing COVID-19. Minor effects were present with mild to moderate pain at the injection site, fatigue, and headache. The incidence of serious adverse effects was low.&nbsp;Pfizer's BNT162b2 phase 2/3 trial findings can be found at the link below.&nbsp;<br>&nbsp;<a class="underline" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2034577" style="color: rgb(0,0,0);">Read More...</a><br></p>
                            </div>
                        </div>
                    </div>
                    <div class="clean-blog-post">
                        <div class="row">
                            <div class="col-lg-5"><img class="rounded img-fluid" src="/assets/img/AZ_Logo_1.jpg?h=dde4154bd5a4bc76976d4116fbf41347"></div>
                            <div class="col-lg-7 text-left">
                                <h3>AstraZeneca is coming up with third vaccine: shows 70% efficacy<br></h3>
                                <div class="info"></div>
                                <p>Positive results are shown from AstraZeneca's clinical trials in the UK, South Africa, and Brazil of their AZD1222 vaccine. One dosing regimen showed vaccine efficacy of 90% when AZD1222 was given as a half dose, followed by a full dose at least one month apart, and another dosing regimen showed 62% efficacy when given as two full doses at least one month apart. The combined analysis from both dosing regimens resulted in an average efficacy of 70%. More data will be accumulating soon. AstraZeneca has not filed EUA with the FDA.&nbsp;AstraZeneca's AZD1222 phase 1 trial vaccine findings can be found at the link below.&nbsp;<br>&nbsp;<a class="underline" href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext" style="color: rgb(0,0,0);">Read More...</a></p>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </section>
    </main><!-- Start: Social Icons -->
    <div class="social-icons" style="background-color: #222425;height: 96px;padding-top: 16px;padding-bottom: 86px;"><a href="#" style="background-color: #222425;"></a><a href="https://www.facebook.com/sannidhi.sarva.25" style="background-color: #222425;"><i class="icon ion-social-facebook"></i></a><a href="https://www.linkedin.com/in/sannidhisarvadhavabhatla/" style="background-color: #222425;"><i class="icon ion-social-linkedin"></i></a><a href="https://instagram.com/sannidhi_sarva" style="background-color: #222425;"><i class="icon ion-social-instagram" style="background-color: #222425;"></i></a>
        <div>
            <p style="color: rgba(238,234,234,0.9);background-color: #222425;height: 85px;margin-bottom: 0px;padding-bottom: 58px;">sannidhisarva@berkeley.edu | 847-226-5080<br><br>© 2021 Sannidhi Sarvadhavabhatla<br><br><br><br><br></p>
        </div>
    </div><!-- End: Social Icons -->
    <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.6.0/js/bootstrap.bundle.min.js"></script>
    <script src="/assets/js/smart-forms.min.js?h=a436bee1e5ae414f98db7ca13adfd7c0"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/baguettebox.js/1.10.0/baguetteBox.min.js"></script>
    <script src="/assets/js/script.min.js?h=df08ff158d8fbc0684304bfe675a3aa2"></script>
</body>

</html>